NL-OMON39013招募中4 期
ong term prospective observational cohort study on the safety and efficacy of abatacept subcutaneus in the daily clinical practice of rheumatoid arthritis - Abatacept subcutaneous in rheumatoid arthritis
Jan van Breemen Instituut0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients * 18 years old at treatment initiation
- •Patients informed and accepting to participate (Written informed consent)
- •Patients diagnosed with established moderate to severe active RA as per the 1987 ACR criteria/2010 ACR/EULAR Rheumatoid Arthritis Classification Criteria
- •Patients who at their physician*s discretion are initiated with abatacept SC.
排除标准
- •Patients currently participating in any interventional clinical trial in RA
- •Contraindications against abatacept SC treatment.
研究者
相似试验
招募中
4 期
ong term prospective observational cohort study of the safety and efficacy of golimumab in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profileinflammatory rheumatic disease1000381610023213NL-OMON36406Jan van Breemen Instituut200
招募中
4 期
ong term prospective observational cohort study of the safety and efficacy of certolizumab pegol in the daily clinical practice of rheumatoid arthritis with emphasis on the lipid profileinflammatory rheumatic disease1000381610023213NL-OMON36770Jan van Breemen Instituut200
已完成
不适用
ong term, prospective, observational cohort study evaluating the safety profile in patients with highly active relapsing multiple sclerosis (RMS) newly started on oral cladribineG35.9DRKS00015267Merck KGaA1,115
尚未招募
不适用
Rate of multidrug resistance to antimicrobial drugs in paediatric neurointensive care patientsCTRI/2019/10/021721All India institute of medical sciences
已完成
不适用
Venous thromboembolism in care homesISRCTN80889792niversity of Birmingham (UK)1,000